AMP 39473011000001103

Search dm+d | This AMP cannot be matched against our prescribing data.

Description COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.)
BNF code 1404000ATBEAAAD
Virtual Medicinal Product Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
Name COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
Abbreviated name COVID-19 Vaccine Nuvaxovid 0.5ml inj multidose vials
Date of name applicability 23 Feb 2022
Previous name COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials
Supplier Novavax CZ a.s.
Current licensing authority Medicines - MHRA/EMA
Previous licensing authority None
Reason for change of licensing authority Licence Granted
Date of change of licensing authority 23 Feb 2022
EMA additional monitoring
Parallel import
Restrictions on availability Restricted Availability
Licensed Route
Licenced route Intramuscular
Actual Medicinal Product Packs
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 100 dose 10 x 10 dose vials
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 10 dose

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback